期刊文献+

药源性肺纤维化的致病药物及临床类型

下载PDF
导出
出处 《中国社区医师(医学专业)》 2010年第27期38-39,共2页
  • 相关文献

参考文献2

二级参考文献23

  • 1Hartmann LC, Frytak S, Richardson RL, et al. Lifethreatening bleomycin pulmonary toxicity with ultimate reversibility. Chest, 1999, 98 (2): 497.
  • 2Lazo JS. Bleomycin. Cancer Chemother Biol Response Nodif. 1999, 18: 39-45.
  • 3Real EI, Roca M J, Vinuales A, et al. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin' s disease. Haenatologica, 1999, 84 (7):667.
  • 4Jules - Elysee K, White DA. Bleomycin - induced pulmonary toxicity. Clin Chest Med, 1990, 11 (1): 1-20.
  • 5Comis RL. Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol, 1998, 16 (9): 3205.
  • 6Willenbacher W, Mumm A, Bartsch HH. Late polmonary toxicity. Clin Chest Med, 1990, 11 (1): 1-20.
  • 7Wolkowicz J, Sturgeon J, Rawji M, et al. Bleomycin- induced polmonary function abnormalities. Chest, 1992, 101(1): 97.
  • 8Kharasch VS, Lipsitz S, Santis W, et al. Long- term polmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.Med pediatr Oncol, 1996, 27 (2): 85.
  • 9Sleijfer S. Bleomycin - induced pneumonitis. Chest,2001, 120 (2): 617.
  • 10Carlson RW, Sikic BJ. Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med, 1983,99: 823.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部